UK-wide Expansion of 32Co's Sleep Centers to Combat Escalating Sleep Disorder Predicament
In a significant stride towards improving sleep health in the UK, London-based healthtech company 32Co has launched pilot locations for its Aerox Sleep Centres this summer [1][2][4]. These innovative centres, set to expand nationwide, are aimed at treating patients with mild to moderate obstructive sleep apnea (OSA) and problematic snoring.
The centres are making waves in the industry by providing access to Mandibular Advancement Devices (MADs), effective and NICE-approved treatments that keep airways open during sleep [1][2]. Historically, MADs could only be prescribed by dental clinicians, but 32Co is upskilling dentists in OSA treatment, connecting them with medical specialists for virtual collaboration [1][2][4].
This approach addresses a longstanding issue in the UK, where millions remain undiagnosed or stuck on long NHS waiting lists due to limited availability of treatment providers [1][2]. By reducing referral times and patient travel burdens, 32Co's Aerox Sleep Centres are set to significantly improve access to OSA treatment.
The impact of these centres is evident. In pre-pilot trials, the Aerox Sleep Centres and MADs have helped hundreds of patients improve their sleep [1]. Moreover, MADs have shown a 25% higher adherence compared to Continuous Positive Airway Pressure (CPAP) machines, with similar improvements in excessive daytime sleepiness (EDS) and quality of life (QoL) [1].
The industry standard treatment method against sleep apnea via CPAP machine is often abandoned due to the mask's discomfort and difficulties in travel [1]. John, 69, from Manchester, stated that he would sleep downstairs with the dog if his device broke [1]. Similarly, Michael, 58, from London, mentioned that he doesn't wake up as tired and grumpy without his device [1].
The problem of snoring is more prevalent than one might think. Around 1 in 4 people in the UK snore or snore problematically, contributing to a major cultural shift known as 'sleep divorces', with 19% of millennials and 14% of Gen Z sleeping in another room consistently [1].
Traditional over-the-counter solutions for snoring have failed to address the root cause. Problematic snoring can lead to chronic sleep disruption, linked to depression, memory loss, diabetes, and fatigue-related accidents [1]. OSA, a condition often associated with problematic snoring, is linked with serious medical conditions, with prevalence as high as 40% to 80% in patients with hypertension, heart failure, coronary artery disease, pulmonary hypertension, atrial fibrillation, and stroke [1].
With estimates suggesting that around 8 million people aged 30-69 years might be affected by OSA in the UK alone (Lancet, 2020) [1], the need for accessible and efficient OSA treatment is paramount. The first pilot centres are in London, Manchester, Edinburgh, and Bristol, with more to follow nationwide [1][2].
32Co has raised £7 million in funding to support this initiative, reinforcing strong investment confidence in this model [1]. The current status of 32Co's Aerox Sleep Centres is that they have recently launched pilot locations in London, Manchester, Edinburgh, and Bristol, with plans for nationwide expansion and a national waitlist open for patients across the UK [1][2][4].
Helen, 64, from London, believes many people would benefit from MADs because they are unobtrusive [1]. By making MADs more accessible, 32Co's Aerox Sleep Centres are set to revolutionize the sleep health landscape in the UK.
[1] 32Co Press Release, 2025. [2] The Guardian, 2025. [4] The Lancet, 2020.
- The Aerox Sleep Centres initiated by 32Co, equipped with mandibular advancement devices (MADs), aim to expand nationwide and address the issue of limited availability of sleep apnea (OSA) treatment providers in the UK.
- Medical plastics, in the form of MADs, have demonstrated a 25% higher adherence rate compared to Continuous Positive Airway Pressure (CPAP) machines, potentially benefitting patients with OSA and problematic snoring.
- In pursuit of improved sleep health in the UK, 32Co is leveraging science to connect dentists with medical specialists for virtual collaboration, upskilling the former to better treat OSA patients.
- By providing a solution to OSA, a condition linked to chronic diseases like hypertension, heart failure, and stroke, the Aerox Sleep Centres are set to contribute significantly to the health-and-wellness sector, potentially benefitting as many as 8 million affected individuals in the UK.
